Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rib Fractures | 1 | 2018 | 33 | 0.550 |
Why?
|
| Independent Living | 1 | 2018 | 116 | 0.520 |
Why?
|
| Skilled Nursing Facilities | 1 | 2018 | 152 | 0.500 |
Why?
|
| Burns | 3 | 2026 | 374 | 0.480 |
Why?
|
| Nerve Regeneration | 4 | 2022 | 58 | 0.370 |
Why?
|
| Axons | 2 | 2022 | 204 | 0.290 |
Why?
|
| Debridement | 1 | 2026 | 85 | 0.230 |
Why?
|
| Chondrogenesis | 2 | 2017 | 88 | 0.220 |
Why?
|
| tau Proteins | 1 | 2025 | 105 | 0.210 |
Why?
|
| Central Nervous System | 1 | 2025 | 282 | 0.190 |
Why?
|
| Hypnotics and Sedatives | 1 | 2025 | 222 | 0.190 |
Why?
|
| Ganglia, Spinal | 2 | 2022 | 88 | 0.190 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2022 | 134 | 0.160 |
Why?
|
| Tibial Nerve | 1 | 2019 | 9 | 0.150 |
Why?
|
| Interleukin-4 | 1 | 2020 | 207 | 0.150 |
Why?
|
| Nociceptors | 1 | 2019 | 40 | 0.150 |
Why?
|
| Homes for the Aged | 1 | 2018 | 33 | 0.140 |
Why?
|
| Electric Stimulation | 1 | 2019 | 277 | 0.140 |
Why?
|
| Tacrolimus | 1 | 2019 | 196 | 0.140 |
Why?
|
| Eosinophils | 1 | 2020 | 316 | 0.130 |
Why?
|
| Thrombosis | 1 | 2020 | 400 | 0.120 |
Why?
|
| Cartilage | 1 | 2017 | 198 | 0.120 |
Why?
|
| Biomarkers | 2 | 2025 | 4302 | 0.110 |
Why?
|
| Chondrocytes | 1 | 2017 | 232 | 0.110 |
Why?
|
| Recovery of Function | 1 | 2019 | 716 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 59 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2019 | 838 | 0.110 |
Why?
|
| Cleft Palate | 1 | 2015 | 91 | 0.100 |
Why?
|
| Comorbidity | 1 | 2018 | 1662 | 0.100 |
Why?
|
| Wharton Jelly | 1 | 2013 | 1 | 0.100 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2013 | 27 | 0.100 |
Why?
|
| Tissue Engineering | 2 | 2017 | 439 | 0.090 |
Why?
|
| Elastin | 1 | 2013 | 78 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2018 | 995 | 0.090 |
Why?
|
| Prognosis | 1 | 2018 | 4329 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2018 | 3752 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2026 | 17322 | 0.070 |
Why?
|
| Aged | 3 | 2025 | 26212 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 8346 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 2602 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2025 | 122 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2025 | 79 | 0.050 |
Why?
|
| Risk Factors | 1 | 2018 | 10916 | 0.050 |
Why?
|
| Humans | 9 | 2026 | 145750 | 0.050 |
Why?
|
| Middle Aged | 4 | 2026 | 36297 | 0.040 |
Why?
|
| Rats | 2 | 2022 | 5585 | 0.040 |
Why?
|
| Rodentia | 1 | 2022 | 61 | 0.040 |
Why?
|
| Sensory Receptor Cells | 1 | 2022 | 98 | 0.040 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2020 | 7 | 0.040 |
Why?
|
| Neuroglia | 1 | 2022 | 174 | 0.040 |
Why?
|
| United States | 1 | 2018 | 16122 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 38100 | 0.040 |
Why?
|
| Length of Stay | 1 | 2026 | 1350 | 0.040 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2019 | 38 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2019 | 63 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 419 | 0.040 |
Why?
|
| Female | 5 | 2026 | 79025 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 138 | 0.030 |
Why?
|
| Adult | 3 | 2026 | 40867 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2019 | 202 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2017 | 121 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 2017 | 128 | 0.030 |
Why?
|
| Elasticity | 1 | 2017 | 189 | 0.030 |
Why?
|
| Male | 4 | 2026 | 72992 | 0.030 |
Why?
|
| Maxilla | 1 | 2015 | 36 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2017 | 494 | 0.030 |
Why?
|
| Cadaver | 1 | 2015 | 311 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2015 | 301 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1478 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 860 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 2191 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2015 | 204 | 0.020 |
Why?
|
| Mice | 2 | 2022 | 18357 | 0.020 |
Why?
|
| Fibrillins | 1 | 2013 | 9 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 429 | 0.020 |
Why?
|
| Fibrillar Collagens | 1 | 2013 | 14 | 0.020 |
Why?
|
| Nanofibers | 1 | 2013 | 23 | 0.020 |
Why?
|
| Swine | 1 | 2015 | 826 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 649 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 135 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1997 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 1897 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 782 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 979 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2013 | 221 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1184 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1300 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 1791 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2770 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4569 | 0.010 |
Why?
|